Peking University Cancer Hospital, Gastrointestinal Oncology

Beijing

1 studies enrolling now · 1 studies all time

What they study most

Gastric / Gastroesophageal Junction Adenocarcinoma

Studies at this site

• Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma — Starting soon